Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243020 · ClinicalTrials.gov registry record · NA
VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke
A NA study, sponsored by MicroTransponder.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02243020: Completed NA study, sponsored by MicroTransponder.
NCT02243020 is a NA study that has completed, run by MicroTransponder. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243020, a NA study, has completed, sponsored by MicroTransponder.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a larger, pivotal study.
Primary Outcome
Measurement of impairment, minimum value 0, maximum value 66, higher score means a better outcome. Subscales are summed.
Interventions
- DEVICE Vagus Nerve Stimulation (VNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-10 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT02243020 record still lists
NCT02243020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation (VNS) is the first listed.
NCT02243020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02243020 about?
NCT02243020 is a clinical study titled "VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke". The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a large...
What is the current status of trial NCT02243020?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-10. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT02243020?
The interventions under investigation include: Vagus Nerve Stimulation (VNS) (DEVICE).
Who is sponsoring clinical trial NCT02243020?
This trial is sponsored by MicroTransponder, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02243020's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia